Literature DB >> 7797923

Hepatitis C virus viremia in SCID-->BNX mouse chimera.

E Galun1, T Burakova, M Ketzinel, I Lubin, E Shezen, Y Kahana, A Eid, Y Ilan, A Rivkind, G Pizov.   

Abstract

Chimpanzees are currently the only nonhuman animal model for reproducible propagation of hepatitis C virus (HCV). A chimeric mouse model was used for the induction of hepatitis C viremia, using BNX (beige/nude/X-linked immunodeficient) mice preconditioned by total body irradiation and reconstituted with SCID mouse bone marrow cells. HCV-infected liver fragments from patients with HCV RNA-positive sera were transplanted under the kidney capsule of the chimeric mice. HCV-specific RNA sequences were detected by reverse transcriptase nested polymerase chain reaction (RT-PCR) in serum of approximately 50% of grafted animals. In addition, normal liver specimens were incubated with HCV serum and transplanted into chimeric mice, leading to viremia in approximately 25% of animals. Sequential histologic evaluation of the liver implants, from day 2 to week 14 after transplantation, revealed loss of lobular architecture within the implants. However, viremia persisted for 10-50 days after transplantation. These results offer a new HCV model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797923     DOI: 10.1093/infdis/172.1.25

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Predictive observation-based endpoint criteria for mice receiving total body irradiation.

Authors:  Elizabeth A Nunamaker; Robert J Anderson; James E Artwohl; Alexander V Lyubimov; Jeffrey D Fortman
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

2.  Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences.

Authors:  A Klein; R Barsuk; S Dagan; O Nusbaum; D Shouval; E Galun
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.

Authors:  Yimin Tong; Yongzhe Zhu; Xueshan Xia; Yuan Liu; Yue Feng; Xian Hua; Zhihui Chen; Hui Ding; Li Gao; Yongzhi Wang; Mark A Feitelson; Ping Zhao; Zhong-Tian Qi
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

4.  Transplantation of human hepatocytes into tolerized genetically immunocompetent rats.

Authors:  E C Ouyang; C H Wu; C Walton; K Promrat; G Y Wu
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 5.  Hepatitis C virus experimental model systems and antiviral drug research.

Authors:  Susan L Uprichard
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

6.  Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens.

Authors:  Nicolas Brezillon; Dina Kremsdorf; Mary C Weiss
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

Review 7.  New animal models for hepatitis C viral infection and pathogenesis studies.

Authors:  Dina Kremsdorf; Nicolas Brezillon
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

8.  HCV animal models: a journey of more than 30 years.

Authors:  Philip Meuleman; Geert Leroux-Roels
Journal:  Viruses       Date:  2009-09-02       Impact factor: 5.048

9.  Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo.

Authors:  Stephen Griffin; Rachel Trowbridge; Pia Thommes; Nigel Parry; David Rowlands; Mark Harris; Helen Bright
Journal:  J Hepatol       Date:  2008-09-15       Impact factor: 25.083

10.  Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant.

Authors:  H Zhang; R Hanecak; V Brown-Driver; R Azad; B Conklin; M C Fox; K P Anderson
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.